Objectives: Based on a qualitative study conducted in Bulawayo, Zimbabwe, this article examines how the availability of HAART since April 2004 may impact the views and choices of HIV-positive couples on childbearing.
Introduction and background
The advent of highly active antiretroviral therapy (HAART) has drastically altered the prognosis of HIV/AIDS. From being a fatal condition over the medium-to long-term, it is now a chronic but manageable condition. The result has been that people with HIV can now live longer, healthier lives unpunctuated From the results of the study, 3 identifiable groups emerged with regard to the issue of HAART, MTCT, and reproduction.
There were those who intended to have children as a result of diminished chances of MTCT and the good health afforded by HAART (positive outlook). Another group encompassed those who desired to have children in the future but were still concerned about the effectiveness of HAART and nevirapine in lowering the chances of MTCT and reducing the negative impact of pregnancy on their health (unsure outlook). Then there were those who, though conceding the effectiveness of HAART in improving the health of HIV-infected people, felt that the risk of MTCT was still high and that HAART may have a negative impact on the foetus. These argued against HIV-positive people having children (negative outlook). Most of the respondents who had a negative outlook already had their desired number of children and as such had no desire or intention to conceive in the future. As a result this article focuses on those who had a desire to have a child or children since they were the ones who were likely to consider the impact of HAART on their reproductive choices.
The negative impact of HIV/AIDS on fertility has been well documented (Sharma et al., 2006; Ntozi, 2002; Zaba & Gregson, 1998) . HIV/AIDS generally lowers the fertility rate of those infected. Although high rates of desire to have children (ranging between 26% and 30% among HIV-positive people) have been documented, the actual fertility rate remained as low as 5% before and soon after the advent of HAART (Klein et al., 2003; Sauer & Chang, 2002; Chen et al., 2001; van Devanter et al., 1998) . This indicated the importance of HIV/AIDS in HIV-positive people's consideration of whether to carry their desire through. It is also notable that historically the medical community has considered HIV a serious barrier to reproduction and has advised and counselled HIV-positive people accordingly (Al-Khan et al., 2003) . This view in the medical fraternity was not limited to the West. In Zimbabwe the majority of health professionals still advise HIV-positive people that it is in their best interests to consider not having children in the future. There was, and in some instances there still is, a regard of HIV as a death sentence in the medical fraternity (Reis et al., 2005) . As a result of the risks and their own conceptualisation of the disease, some HIVpositive people are anti-conception; others are pro-conception while others are undecided.
With the advent of HAART and its increased uptake both in the developed and developing world there was bound to be an impact both on fertility and reproductive plans of HIV-positive people. Studies that have been carried out in this area so far indicate a positive impact of HAART on fertility. Sharma et al. (2006) investigated the relationship between HIV infection and childbearing before and after the availability of highly active antiretroviral therapy among HIV-positive and HIV-negative women. They found that among HIV-infected women, the HAART era live birth rate was 150% higher than in the pre-HAART era versus a 5% increase among HIV-uninfected women in the same period. In a study to explore pregnancy outcome in HIV-1-positive and HIV-negative women under the era of HAART, Boer et al., (2007) found that MTCT was 0% among HIV-positive women irrespective of mode of delivery.
In a separate study Castro et al. (2007) indicated that there has been a rapid increase in pregnancies in HIV-positive women since the introduction of HAART in Cuba. Thus it seems HAART has not only altered the clinical course of HIV but has also had an impact on the reproductive views and choices of people with HIV/AIDS.
Noting that most of the studies on the impact of HAART on reproductive and sexual issues have been carried out in the developed world where the therapy has been available for years (Semprini & Simona, 2004; Thornton et al., 2004) , this paper examines the emerging scenario in Zimbabwe. It advances and explores the idea that the improvement in health and reproduction prognosis which is associated with the use of HAART plays a significant role in shaping the reproductive views of HIV-positive couples studied. Table 1 .
Methods

Study design
Informed consent was obtained from every participant before the interview was conducted. The consent form, which every participant and the researcher signed, explained the purpose and procedure of the study as well as the rights of the participant. Permission to tape-record the interview was sought from the participants and there was no instance in which it was refused. The participants were made aware of their right not to answer any question that they did not want to. It was also within their rights to discontinue the interview when they decided that they no longer wanted to carry on and they were informed of this. For confidentiality reasons the respondents' names were not used in the study report.
The man and woman in a couple were interviewed separately in a bid to elicit their individual views and to minimise gender and partner bias, since in the presence of a man or men some women may not find it possible to express themselves openly, and vice versa. The interviews were conducted in places chosen by the couples. Couples were eligible to participate if both or one of them was HIV-positive, they were in an intimate relationship, had disclosed their HIV-positive status to each other and if they were confronting, will be confronting or had confronted reproductive decision-making and able to complete the interview in Ndebele, Shona or English.
Two strategies were used to recruit respondents. One was to recruit willing participants from support groups and opportunistic infections clinics through distributing recruitment flyers and the other was snowball sampling.
Snowballing was used in this study as it offers better chances of accessing hard to reach and stigmatised groups like HIV-positive people. Usually in a 'closed group' a link exists between the initial sample and others in the same Original Article target population, allowing a series of referrals to be made within a circle of acquaintance (Berg, 1988) . The initial couples who came forward after administering the recruitment flyer were asked after the completion of the interviews if they knew another couple or couples that would be willing to participate in the study. In this way the researcher moved from one couple to the next and managed to access most of the respondents in this study that would otherwise have been missed. However, the main problem with this method was the production of a somewhat homogeneous and atypical sample which was not representative of all HIV-positive couples in Bulawayo, since referrals were dependent on the social networks of the respondents first accessed. Due to the selection bias which produced a particular group of respondents with close inter-relationships the results of this study are not generalisable. However, though claims to generalisability cannot be made based on this sample, the results reveal a number of important issues in relation to reproduction among HIV-positive couples.
Data analysis
Data were analysed using a grounded theory approach, based on a process that helps researchers to 'discover' categories, themes and patterns that emerge from the data. Taped interviews were transcribed in the original language and then translated into English. Transcribed interviews were then content analysed to identify patterns and themes concerning reproduction among HIV-positive people. The strategies used in the data analysis were a systematic review and a thoughtful reading of interview data, coding, memo writing; categorising and sorting for patterns and the construction of the story told.
Results
Fifteen couples were interviewed. Nineteen respondents indicated that they still desired to have a child. These can be divided into two groups, i.e. those with a desire but no intention to have a child in the immediate future and those who intend to have a child in the immediate future. There were also some respondents who felt that instead of having a positive impact prophylactic drugs would have a harmful effect on the foetus while some respondents expressed no opinion on this issue.
Reasons for desiring children
There were a number of reasons that these couples and 
Desire but no intention to have a child
Eleven of the respondents fell within this group. A number of reasons were proffered for this stance but the main one related to their uncertainty over the efficacy of HAART in mitigating the risk of vertical transmission. Most of the respondents were terrified of transmitting the virus to their unborn child. These were some of their responses. Most respondents in this group were concerned that HAART was a relatively new form of therapy whose effectiveness and usefulness in mitigating vertical transmission and adverse effects of pregnancy had not been proven. As a result, though they desired to have children, they would wait until such a time that the effectiveness of this therapy in reproduction had been proven.
There was also concern among this group about the impact of 
From desire to intention
The 
But since I began ARVs I am back to my normal self. '
Nearly all those on ARVs had similar stories of rising from their death beds to lead almost normal healthy lives with some, like C12M, going back to work. C14M, who was not on therapy, also indicated that he had seen many people who had 'unbelievably risen from death' as a result of HAART. With their health assured as a result of HAART the couples and individuals studied felt that they could take the chance and have a child. As Couple 12 indicated, HAART gave them 'an assurance and hope that they could at least live a healthy life, have children and raise them' .
A number of respondents noted that as a direct result of HAART, their CD4 cell count had gone up and their viral load was steadily declining. The link between this and MTCT was not lost to them. All those who intended to have children were aware that a high CD4 cell count and diminished viral loads meant a diminished MTCT risk. Though most of them put the chances of MTCT at between 5 -30% when one is on HAART (actual risks are much lower at 0 -2%) to them these were relatively low percentages to warrant the risk.
Commenting on the low chances of MTCT when one is on HAART C5F said: It has been shown that CD4 cell count and HIV RNA levels are related to the likelihood of disease progression in the mother and also the risk of vertical transmission (Sullivan, 2003) . A high CD4 cell count is associated with a lowered risk of vertical transmission while a low maternal CD4 count is similarly associated with higher transmission risk of HIV. (Boer et al., 2007; Ioannidis et al., 2001; Maiques et al., 1999) The optimism of people on HAART was therefore not misplaced.
Furthermore, a number of studies have demonstrated low
MTCT in the setting of HAART (Boer et al., 2007; Cohan, 2003) . The lowest transmission prevalence observed is among women with maximally suppressed virus at the time of delivery and, as Cohan (2003) notes; this is most likely to occur among women on HAART. Recent studies have also shown that MTCT rates may be as low as 1 -2% in women with HIV RNA levels of below 1 000 copies/ml regardless of mode of delivery (Minkoff, 2003; Cooper et al., 2002; Dorenbaum et al., 2002; ) .
HIV-positive people with a low HIV RNA as a result of HAART thus have an over 98% chance of having an HIV-negative child.
The effectiveness of nevirapine as a single-drug therapy has also been noted in reducing MTCT to around 5% among those who are not on HAART (Conway, 2005) . Thus being on HAART, a high CD4 cell count and the use of nevirapine are all factors consistent with a greater chance of having an HIV-negative child as noted by the study respondents.
People who intended to have children in this study seemed to Talking of her impending intention to try again for a child C12F There was high optimism in this group about their chances of having an HIV-negative child. This optimism was not based solely on their improved health as a result of HAART but also on the information they have on its efficacy and on other strategies that can be used in ensuring that the risks of vertical transmission are reduced both pre-and postnatal.
Strategies for reducing MTCT risk and reinfection
The respondents cited a number of strategies that can be used to reduce the risk of MTCT and re-infection apart from being on HAART and nevirapine. These included having unprotected sex only during the woman's fertile period and the practice of safe sex as soon as the woman becomes pregnant to reduce the viral load and the chances of infecting the foetus with drug-resistant HIV strains. '...one counsellor told me that we should only have unprotected sex during her fertile period so as to reduce chances of re-infection' said C1M. C12, C5M also indicated that they had been given similar advice.
Contraindicated drugs in pregnancy
There was mention of avoidance of contraindicated drugs in pregnancy for the sake of the foetus. C12F and C5F indicated that there are certain drugs in triple therapy, like efavirenz, which are unsuitable for a pregnant mother as they may cause malformations of the foetus. C12F said that a nursing sister had advised her that 'if you become pregnant we will change your drug
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regimen' so as to reduce risks to the unborn child. C5F, probably using her medical knowledge, pointed out that '…there are some ARV drugs that are not suitable for a pregnant woman' . The issue of in utero exposure of the foetus to ARVs and the possible adverse effects this can have on it is still somewhat a grey area where research is still ongoing. There are drugs, like efavirenz, mentioned previously, that are contraindicated in pregnancy as a result of its association with congenital anomalies. The jury is still out on the association of ARVs with mitochondrial toxicity, malignancies, and congenital anomalies on babies exposed in utero. Some small studies have found association of ARVs with these conditions while larger cohort studies have found no increase in any specific foetal abnormality, neonatal condition or low birth weight with currently recommended antiretroviral regimens (Ammann, 2007) . There is also mixed evidence regarding the association between combination antiretrovirals and premature delivery (AIDS, 2001; Tuomala et al.; 2002; JAIDS, 2003) . Notwithstanding this, the information that those who intend to have children have seems to be generally sound.
Given the information they have, their hope and optimism of having HIV-negative children is to be expected.
Breastfeeding
Breastfeeding was also indicated as another way that the mother may infect her child, and most of the respondents indicated that it was best for the mother not to breastfeed. C4F indicated that '…we are taught (in support groups) about the dangers of breastfeeding and some other options of feeding the baby' . C12F added, '…I do not think I will breastfeed. They say breastfeeding can transmit the virus to the baby' .
A number of studies have demonstrated the role of breastfeeding in HIV transmission (Coovadia et al., 2007; Willumsen et al., 2003; Fawzi et al., 2002) . In a study carried out in Kenya it was found that breastfeeding increased the risk of transmission by as much as 16% (Nduati et al., 2000) . In the study 44% of MTCT was attributable to breastfeeding. Even in the era of HAART it has been found that breastfeeding significantly increases the risk of MTCT (Coovadia et al., 2007; Kilewo et al., 2007; Arendt et al., 2007) . Thus to eliminate the risk of infecting the infant through breastmilk the mother has to forgo breastfeeding altogether. Though this is a difficult choice in resource-poor settings like Zimbabwe, where most of the respondents lived below the poverty datum line, those who intend to have children pointed out that they would opt for this option to maximise their chances for an HIV-negative child.
Caesarean section
C5F and C12 indicated that given the risks of transmitting the virus to the child during birth they would opt for an elective The role of elective C-section in reducing MTCT has been well noted (European Collaborative Study, 2005; Posokhova et al. 2004; Lancet, 1999; NEJM, 1999) . However, some studies have found no significant differences in transmission prevalence among women with vaginal deliveries (0.8%), elective C-section (0.8%) and non-elective C-section (1.1%) .
Although some studies have found a potential protective role of elective C-section among women with HIV RNA levels greater than 1000 copies/ml many study results point to the significant morbidity associated with caesarean delivery among HIVinfected women (Marcollet et al., 2002; Watts et al., 2000; Read, 2000) . It is therefore important for those on HAART to consider this mode of delivery carefully with their GPs. The health professionals also have to provide up-to-date, appropriate and unprejudiced information to infected couples so as to enable those who want to have children to make informed decisions.
The centrality of HAART in reproductive planning
What was notable among those who intended to have a child or children in the near future was the centrality of HAART in their reproductive plans. The respondents pointed out that had it not been for HAART they would not have considered having a child or children in spite of all other social and cultural factors they 
The impact of prophylactic drugs on the foetus
A few respondents felt that HAART and nevirapine may pose a risk to the unborn child. Among these two were on HAART (C2F, C8F) while one was not (C7F It is notable that both these women had children that were born when they were already positive. C7F discovered her status after she gave birth to an HIV-positive child while C8F discovered her status during pregnancy. Even though she (C8F) went through the Prevention of Parent to Child Transmission (PPTCT) programme and her 2-year-old child was HIV-negative she attributed the negativity of her child to miracles. She was not fully convinced of the efficacy of nevirapine and HAART on preventing MTCT of HIV to the unborn baby. The fears and concerns of these people with regard to in utero effects of ARVs on the foetus were not largely misplaced, as indicated on the discussion of the issue above. Nonetheless, their views on this and on the risk of MTCT even when one is on HAART points to the need for more relevant information regarding these issues to be made available to HIV-positive people.
Discussion
Three important issues with regard to childbearing emerged from the people who intended to have children. These related to HAART, mode of delivery should they conceive and their preferred mode of infant feeding. All these issues had an impact on their views on childbearing and to some on their decision to conceive. As Sauer (2003) notes, although AIDS remains a serious disease which, if not treated, can lead to death, with appropriate medical intervention the disease usually revolves towards chronicity and patients generally enjoy years of good health. This view of the disease was beginning to take root among those on therapy, with most in the study reporting that they now perceived it to be just like any other debilitating or chronic disease. The health that they had enjoyed since commencing therapy made them see AIDS as a manageable disease whose progression could be successfully controlled through a cocktail of antiretroviral drugs, diet and safe sexual practices.
With such an outlook it is not surprising therefore to see an increase in the percentage of HIV-positive people who intend to have children, since they see themselves living longer and more productive lives (Boer et al., 2007) . from the study results is that HAART had a significant impact on the reproductive plans of those who intended or desired to have children. Where previously they only 'dreamed' of having a child, they could now make that dream a reality. It is significant to note that all those who intended to have children pointed out that in the absence of HAART they would not have considered having a child. HAART seems to have been the foundation upon which they built their hope of having a negative child whom they could bring up themselves. The study results also point to the need to provide more relevant information on the issues discussed as there was some uncertainty and knowledge gaps among others who desire to have children about the efficacy of HAART in mitigating MTCT, and on the impact of pregnancy on the health of the woman.
